Word

MEDICINE IN THE FUTURE WILL NOT NEED CELLS

Status

Pending

Status Code

680

Status Date

Friday, October 4, 2024

Serial Number

98188567

Mark Type

4

Filing Date

Wednesday, September 20, 2023

Trademark Owner History

MAM HOLDINGS OF WEST FLORIDA, L.L.C.

Classifications

40 Providing technical information in the field of manufacturing biomaterials, pharmaceuticals, regenerative medicine products, and biologics, and their manufacturing; biomanufacturing for others in the nature of processing of medical materials, namely, custom fabrication, and assembly of biologics for research, development, and medical purposes, using biological materials in the manufacturing process; biologic manufacturing for others, namely, isolating and processing biologic tissue products using human placental and birth tissues in the manufacturing process for use in regenerative medicine; custom biologic manufacturing for others, namely, isolating and processing biologic products from human placental and birth tissues for use in regenerative medicine; custom manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics for others; biomanufacturing for others, namely, manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics, pharmaceuticals, regenerative medicine products, and biologics using biological materials in the manufacturing process; technical consulting related to the manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics; treatment of materials for the manufacture of biomaterials, pharmaceuticals, regenerative medicine products, and biologics, by means of cryogenic processing; biomanufacturing for others in the nature of processing of biomaterials for use in manufacture of pharmaceuticals, regenerative medicine products, and biologics; cryogenic preservation services of biologics; processing of medical materials, namely, custom fabrication, and assembly of biologics for therapeutic purposes using biological materials in the manufacturing process; and biologic manufacturing for others, namely, isolating and processing biologic tissue products using human placental and biologic birth tissues for use in regenerative medicine

5 Pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and sports related injuries; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the prevention and treatment of cancer, and suppressing tumors; pharmaceutical products for regenerative medicine, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders; biologically derived products developed from perinatal tissue and fluid material for medical and medical regenerative purposes; bioengineered placental biomaterials for medical purposes; biologics, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders; tissue-regenerative medical preparations, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders; therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; and pharmaceutical preparations, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and delivery systems therefor sold as a unit, for use in regenerative medicine

37 sterilizing of human amniotic fluid

35 Wholesale ordering services, online retail ordering services, retail store ordering services, and catalog ordering services featuring medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; distributorship services in the field of medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; wholesale services by direct solicitation by sales agents in the field of pharmaceutical, regenerative medicine products, and biologics; publicity and sales promotion relating to goods and services; on-line wholesale and retail store services featuring pharmaceutical, regenerative medicine products, and biologics, also accessible by telephone, facsimile, and mail order; and wholesale store services for pharmaceutical preparations and medical supplies

42 Development of biomedical and pharmaceutical products, preparations and medicines; pharmaceutical and biomedical product evaluation; research and development services in the field of medical preparations, biologics, and regenerative medicine and consultancy services relating thereto; scientific investigations for medical purposes; laboratory research in the field of regenerative medicine, biomedical products, and pharmaceuticals; medical research laboratory services and scientific laboratory services; biomedical research services; biotechnology research; chemical research; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; drug discovery services; industrial research in the field of regenerative and reparative medical therapies; medical research; pharmaceutical drug development services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields; scientific research and development; technology research in the field of regenerative and reparative medical therapies; pharmaceutical, medical, and scientific research and development services in the fields of cell therapy, gene therapy, oncology, immunotherapy, and regenerative medicine; scientific research for medical purposes in the area of regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; providing medical and scientific research information relating to medical treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration; clinical research in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and pharmaceutical preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of pharmaceutical preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and tissue generation, processing and transplantation; scientific and technological services and research and design relating thereto, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials, and pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials

Trademark Events

Oct 5, 2023

New Application Office Supplied Data Entered

Sep 23, 2023

New Application Entered

May 2, 2024

Correspondence Received In Law Office

Feb 2, 2024

Assigned To Examiner

Feb 8, 2024

Non-Final Action Written

Feb 8, 2024

Non-Final Action E-Mailed

Feb 8, 2024

Notification Of Non-Final Action E-Mailed

May 2, 2024

Teas Response To Office Action Received

May 2, 2024

Teas/Email Correspondence Entered

Aug 22, 2024

Approved For Pub - Principal Register

Sep 11, 2024

Notification Of Notice Of Publication E-Mailed

Sep 16, 2024

Withdrawn From Pub - Og Review Query

Oct 1, 2024

Previous Allowance Count Withdrawn

Oct 3, 2024

Examiners Amendment -Written

Oct 3, 2024

Examiners Amendment E-Mailed

Oct 3, 2024

Notification Of Examiners Amendment E-Mailed

Oct 3, 2024

Examiner's Amendment Entered

Oct 4, 2024

Approved For Pub - Principal Register